Mainz Biomed NV (MYNZ) stock has fallen -86.97% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives MYNZ stock a score of 34 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 1. MYNZ's rank also includes a short-term technical score of 6.
MYNZ has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on MYNZ!
Mainz Biomed NV (MYNZ) stock is trading at $1.14 as of 1:05 PM on Friday, Nov 24, of $0.00, or 0% from the previous closing price of $1.14. Volume today is below average. So far 100,395 shares have traded compared to average volume of 170,196 shares. The stock has traded between $1.11 and $1.15 so far today.
Click Here to get the full Stock Report for Mainz Biomed NV stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
